Australian biotechs attract strong interest at US investor meeting
Monday, 23 January, 2012
For the fifth year, AusBiotech has managed a presentation of Australian companies to San Francisco for an investor showcase held in conjunction with invitation-only the 30th JP Morgan Annual Healthcare Conference in the US.
The event held on the 9 January was again successful in attracting investors – this year 280, with a large contingent from China and Hong Kong – providing a valuable platform for Australian companies seeking investment and partnerships. Presenting companies included:
- Alchemia (ASX:ACL)
- Genetic Technologies (ASX:GTG)
- Phylogica (ASX:PYC)
- Sunshine Heart (ASX:SHC)
- Uptake Medical
- Viveve
AusBiotech has established a calendar of international and local investor showcase events. The next events on the international calendar are:
- Australian Life Science Showcase: Hong Kong 2012 - Wednesday 23 May 2012
- Australian Life Science Showcase: New York 2012 - Friday 15 June 2012 (just prior to BIO2012 convention in Boston)
- Australian Life Science Showcase: Edinburgh 2012 -Wednesday 3 October 2012
- Australian Life Science Showcase: London 2012 - Friday 5 October 2012
Upcoming local events include:
- ‘Brokers meet Biotech' Luncheon - Tuesday 28 February 2012, Melbourne, Victoria
- Medtech Investment Showcase - Monday 14 May 2012 (preceding AusMedtech annual conference), Sydney
- Australasian Life Sciences Investment Summit 2012 - Friday 2 November (part of the AusBiotech 2012 conference), Melbourne
For further information see www.ausbiotech.org/investment.
ADHD drug shows promise for treating meth addiction
A prescription medication used to treat attention deficit hyperactivity disorder (ADHD) could be...
Quitting smoking increases life expectancy even for seniors
Although the benefits of quitting smoking diminish with age, there are still substantial gains...
Stem cell transplants treat blindness in mini pigs
Scientists have successfully transplanted retinas made from stem cells into blind mini pigs,...
